CGTLive’s Weekly Rewind – February 16, 2024

News
Article

Review top news and interview highlights from the week ending February 16, 2024.

CGTLive’s Weekly Rewind – February 16, 2024

CGTLive’s Weekly Rewind – February 16, 2024

Welcome to CGTLive®’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. FDA Pushes Rocket’s LAD-I Gene Therapy PDUFA for CMC Review

Rocket submitted additional CMC data in response to FDA information requests.

2. Salvador Rico, MD, PhD, on A Multi-Pronged Approach to Tackling Dravet Syndrome

The chief medical officer of Encoded Therapeutics discussed ETX101 gene therapy and other initiatives in the company’s overall Dravet program.

3. European Commission Approves Exa-Cel for SCD and TDT

The approval follows the separate US approvals in December 2023 and January 2024.

4. Heather Lau, MD, MS, on Addressing Unmet Needs in MPSIIIA With Gene Therapy

The executive director of global clinical development at Ultragenyx Pharmaceutical discussed UX111, the company’s investigational gene therapy for MPSIIIA.

5. IND Cleared for First RNA Exon Editor Therapy, Trial to Initiate in Stargardt Disease

Ascidian Therapeutics presented positive preclinical data at the 2023 ASGCT meeting.

Recent Videos
Ben Samelson-Jones, MD, PhD, assistant professor pediatric hematology, Perelman School of Medicine, University of Pennsylvania and Associate Director, Clinical In Vivo Gene Therapy, Children’s Hospital of Philadelphia
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Steven W. Pipe, MD, a professor of pediatric hematology/oncology at CS Mott Children’s Hospital
Haydar Frangoul, MD, the medical director of pediatric hematology/oncology at Sarah Cannon Research Institute and Pediatric Transplant and Cellular Therapy Program at TriStar Centennial
Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Caroline Diorio, MD, FRCPC, FAAP, an attending physician at the Cancer Center at Children's Hospital of Philadelphia
R. Nolan Townsend; Sandi See Tai, MD; Kim G. Johnson, MD
Paul Melmeyer, MPP, the executive vice president of public policy & advocacy at MDA
Arun Upadhyay, PhD, the chief scientific officer and head of research, development, and Medical at Ocugen
Related Content
© 2024 MJH Life Sciences

All rights reserved.